Skip to main content
. 2022 Mar 24;16(3):e0010325. doi: 10.1371/journal.pntd.0010325

Table 3. Cost-effectiveness results (per person) for the base-case analysis in the Brazilian Amazon in 2020 United States Dollars (US$).

Strategy Effectivenessa Incremental effectiveness Cost (US$) Incremental cost (US$) ICERb (US$ /incremental outcome)
Routine strategy 0 - 7.0058 - -
G6PDd screening strategy 0.00172 0.00172 7.8582 0.8524 495.32

a. Effectiveness for the outcome PQ-associated hospitalization avoided

b. ICER, incremental cost-effectiveness ratio.